Bayer’s Eylea set for longer treatment intervals to challenge Roche’s Vabysmo
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea 8mg.
An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea 8mg.
What's Your Reaction?
